U.S. Industrial REITs Stock News

If you are looking for the next move on Cirrus Logic (CRUS), this week’s news may have caught your eye. The company just expanded its collaboration with GlobalFoundries, aiming to bring highly efficient and powerful chip technologies to market—from consumer gadgets to cars. This partnership goes beyond a routine announcement, as it promises fresh manufacturing capacity in the U.S. along with advances in critical chip technologies such as BCD process and Gallium Nitride, which could shape...

Mercury General (MCY) has been gaining attention after being tagged as a “Strong Buy” by Zacks and called out for its attractive value metrics compared to competitors. This spotlight arrives on the heels of several positive catalysts, including a rise in net premiums, better investment income, and an updated umbrella insurance product newly launched in Florida. These factors have fueled talk about MCY's underlying business strength and whether the recent run-up is a sign of deeper,...

Axsome Therapeutics (AXSM) just dropped some news that should have every shareholder paying attention. Apotex has officially filed an ANDA with the FDA, complete with a Paragraph IV certification, aiming to launch a generic version of Symbravo. This move signals the possibility of a legal battle over patents, which could determine how long Symbravo remains protected from generic competition. For investors, that means the stakes are high. Any change in exclusivity could reshape revenue streams...

With the business potentially at an important milestone, we thought we'd take a closer look at Axogen, Inc.'s...

Powell Industries (POWL) just made a splash, announcing a $12.4 million expansion at its Jacintoport manufacturing facility in Houston. With this move, the company is increasing production capacity by 62% and doubling the shoreline bulkhead, both clear signals that management sees bigger business on the horizon. While this fresh capital is aimed primarily at serving Oil & Gas clients, there is flexibility built in for other markets as well. For investors, anytime a company puts serious money...

SelectQuote ( NYSE:SLQT ) Full Year 2025 Results Key Financial Results Revenue: US$1.53b (up 16% from FY 2024). Net...

When you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could lose...

Hovnanian Enterprises ( NYSE:HOV ) Third Quarter 2025 Results Key Financial Results Revenue: US$800.6m (up 11% from 3Q...

Yiren Digital ( NYSE:YRD ) Second Quarter 2025 Results Key Financial Results Revenue: CN¥1.65b (up 10% from 2Q 2024...

Hamilton Beach Brands Holding Company's ( NYSE:HBB ) price-to-earnings (or "P/E") ratio of 6.3x might make it look like...

The board of Insteel Industries, Inc. ( NYSE:IIIN ) has announced that it will pay a dividend of $0.03 per share on the...

Key Insights Institutions' substantial holdings in Allient implies that they have significant influence over the...

TrustCo Bank Corp NY's ( NASDAQ:TRST ) periodic dividend will be increasing on the 1st of October to $0.38, with...

Earlier this month, Marriott International completed a multi-part fixed-income offering totaling over US$1.4 billion, issuing callable senior unsecured notes with fixed rates and due dates ranging to October 2035, and expanded its banking partnerships to include institutions such as Wells Fargo, PNC, Scotia, Truist, and others. This transaction not only enhances Marriott's liquidity and financial flexibility but also underscores strong investor and institutional confidence in the company's...

In August 2025, Centene Corporation faced several securities class-action lawsuits after withdrawing its 2025 financial guidance, citing lower than expected market growth and less favorable morbidity trends identified by an independent actuarial review. This wave of litigation has intensified scrutiny on Centene's prior disclosures and raised concerns about transparency and reliability in reporting business fundamentals. We'll now examine how renewed questions regarding Centene's financial...

Virtus Investment Partners recently announced that its Board of Directors approved a 7% increase in its quarterly common stock cash dividend, raising it from US$2.25 to US$2.40 per share, payable on November 14, 2025 to shareholders of record as of October 31, 2025. This move highlights the company's focus on returning capital to shareholders and reflects management’s confidence in the firm’s ongoing performance. We’ll now explore how this dividend increase strengthens Virtus Investment...

Palantir Technologies recently reported record-breaking Q2 results, with its U.S. Commercial segment surpassing expectations and company guidance raised sharply for the remainder of 2025. Analysts have responded by significantly increasing earnings estimates, reflecting growing confidence in Palantir's ability to sustain rapid revenue growth and operational profitability. We'll explore how management's strong guidance lift influences Palantir's current investment narrative and investor...

MetLife, Inc. declared a range of preferred stock dividends in August 2025, including both fixed and floating rate instruments with payouts scheduled for September 15, 2025, to shareholders of record as of August 29, 2025. A key development is MetLife Investment Management’s appointment of Geert Henckens as global head of Private Fixed Income, underscoring a push toward private asset investments and diversification opportunities. To assess how this new leadership in private fixed income...

If you are watching LegalZoom.com (LZ) right now, you might be wondering what today's launch of attorney-assisted provisional patent application services could mean for your investment decision. By moving deeper into intellectual property legal services, LegalZoom is signaling it wants a larger slice of the innovation economy, one that has long been out of reach for many startups and solo inventors. This new offering addresses classic hurdles in patent protection, promising inventors a...

Here’s something for GE Vernova (NYSE:GEV) watchers to note. After a mixed run through spring and early summer, the company’s stock just closed at $607.07, reflecting virtually no movement on the day. While there is no major headline event driving the action, the relative calm might have investors wondering if the current price holds hidden signals about what could be next for the power and energy infrastructure company. Put in context, GE Vernova’s journey in the past year has been anything...

RTX (RTX) grabbed headlines this week after a relatively flat session, with the stock closing at $156.24, down just slightly from the previous day. It is not a splashy move, but it raises the question for investors: Are we simply seeing a pause, or is this a signal that the market is growing more cautious after a year of strong gains? In a year marked by both broader market optimism and persistent macro uncertainty, even minor movements in big names like RTX tend to get noticed. Looking at...

LightPath Technologies, Inc. ( NASDAQ:LPTH ) shares have continued their recent momentum with a 26% gain in the last...

If you have been tracking Ultragenyx Pharmaceutical (RARE), the latest regulatory move may have caught your eye. The company just kicked off a rolling submission for its Biologics License Application to the FDA, targeting approval for DTX401, an AAV gene therapy designed for Glycogen Storage Disease Type Ia. This step is backed by data from its Phase 3 trial, with encouraging reductions in patient daily cornstarch needs. It is also supported by several FDA designations that signal a real...

What are the early trends we should look for to identify a stock that could multiply in value over the long term...